News & Updates

2110, 2020

MammaPrint® Approved for Reimbursement in Germany

October 21st, 2020|

IRVINE, Calif., Oct. 21, 2020 /PRNewswire/ -- Agendia Inc., a world leader in precision oncology for breast cancer, announced today that the Federal Joint Committee (G-BA) has approved MammaPrint® , Agendia's 70-Gene Breast Cancer Recurrence Assay. The G-BA Read More